• Experience in conducting global clinical trials by managing multi-functional international study teams in adherence to ICH Guidelines and other applicable regulations
  • Expertise in the design, feasibility assessment, and planning of single and multi-center Phase I-IV clinical trials
  • Experience in compiling and writing technical documents such as investigational drug brochures, protocols, informed consents, and clinical study reports
  • Expertise in qualifying, selecting, training, managing field-based study monitors and medical monitors against clinical trial needs
  • Expertise in creating and implementing Monitoring, Audit, Data Management, and Trial Master File plans
  • Expertise in investigational drug accountability procedures including for controlled substances

MSA News

Dr. Kenneth Dretchen PhD has been appointed as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee.

May 22, 2020 This committee review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches that…

Read More

Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis

The second in a series of three studies measured the pharmacokinetic and heart rate effects of intranasal epinephrine in dogs….

Read More

Mesa Science Associates and Bryn Pharma Publish Pre-Clinical Study of a New Approach to Treating Anaphylaxis

April 13, 2020 Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three…

Read More